Phoenix has developed a range of Nerium oleander extract (NOE) based products with different compositional profiles resulting from their respective methods of manufacture. Some of the products contain oleandrin and others do not.  In each case, however, the products contain components derived from plant.

The varying compositional profiles results in products exhibiting different biological activities.  Each of the products, however, is safe and effective when used as directed. This is because the products are effective even when administered at doses that are well below toxic doses. Please refer to our information on safety and therapeutic window.

For more information on a specific product, hover over and click on the product code below.

PRODUCT

PBI-05204
OLEANDER-4X
PBI-01207
PBI-01220
PBI-06150
PBI-01011
PBI-04711

TARGET USE

Cancer, Viral Infection, Immune support, Neuroprotection, Neurodegenerative disease
__

Reduction of flu-like symptoms
__

Cancer, Viral Infection, Immune Support, Neuroprotection, Neurodegenerative disease
__

Viral Infections
__

Viral Infections
__

Neuroprotection, Neurodegenerative disease
__

Neuroprotection, Neurodegenerative disease

DEVELOPMENT STAGE

 

Cancer: Phase 1 & 2 complete

__

Available for human use
__

Cancer: Phase 1,
Available for human use under CUIND

__

Preclinical
__

Preclinical
__

Exploratory

__

Exploratory